Literature DB >> 12701117

Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.

Michael Y Shapira1, Pavel Kaspler, Simcha Samuel, Shmuel Shoshan, Reuven Or.   

Abstract

To establish the safety of using G-CSF in healthy PBSC donors, we prospectively determined the degree of DNA destabilization in peripheral blood WBC. Donors were treated with SC G-CSF for 5 days. A baseline sample of peripheral blood was collected before G-CSF treatment and consecutive samples were collected on day 5, 1 month, and 2 months after treatment. The extent of double-stranded DNA relaxation and de novo synthesis of DNA was determined in each sample. We found that both parameters of DNA destabilization were significantly increased after 5 days of G-CSF and returned to baseline level at 1 and 2 months. We assume that these findings suggest that rhG-CSF administration to healthy PBSCT donors for 5 days may be a safe procedure. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701117     DOI: 10.1002/ajh.10324

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  G-CSF in Healthy Allogeneic Stem Cell Donors.

Authors:  Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-22       Impact factor: 3.747

Review 2.  A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.

Authors:  B E Shaw; D L Confer; W Hwang; M A Pulsipher
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

Review 3.  Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.

Authors:  Paolo Anderlini
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

4.  Second cancers in patients with the Ewing sarcoma family of tumours.

Authors:  Fariba Navid; Catherine Billups; Tiebin Liu; Matthew J Krasin; Carlos Rodriguez-Galindo
Journal:  Eur J Cancer       Date:  2008-03-18       Impact factor: 9.162

5.  Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.

Authors:  Gregory S Calip; Judith A Malmgren; Wan-Ju Lee; Stephen M Schwartz; Henry G Kaplan
Journal:  Breast Cancer Res Treat       Date:  2015-10-08       Impact factor: 4.872

6.  Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.

Authors:  Yan Su; Lijun Wang; Xisi Wang; Zhixia Yue; Tianyu Xing; Wen Zhao; Qian Zhao; Chao Duan; Cheng Huang; Yi Han; Lihua Qiu; Xianfeng Cheng; Yi Liu; Xiaoli Ma
Journal:  Cancer Med       Date:  2019-02-21       Impact factor: 4.452

7.  Cancer incidence in healthy Swedish peripheral blood stem cell donors.

Authors:  Simon Pahnke; Ulla Axdorph Nygell; Jan-Erik Johansson; Annika Kisch; Per Ljungman; Anna Sandstedt; Hans Hägglund; Gunnar Larfors
Journal:  Bone Marrow Transplant       Date:  2022-03-07       Impact factor: 5.174

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.